First Time Loading...
O

Oncolys Biopharma Inc
TSE:4588

Watchlist Manager
Oncolys Biopharma Inc
TSE:4588
Watchlist
Price: 706 JPY -0.56% Market Closed
Updated: May 2, 2024

Oncolys Biopharma Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Oncolys Biopharma Inc
Cash from Operating Activities Peer Comparison

Comparables:
2160
4587
4974
J
7774
S
4599

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
O
Oncolys Biopharma Inc
TSE:4588
Cash from Operating Activities
-¥1.3B
CAGR 3-Years
3%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
GNI Group Ltd
TSE:2160
Cash from Operating Activities
¥6.5B
CAGR 3-Years
68%
CAGR 5-Years
61%
CAGR 10-Years
N/A
PeptiDream Inc
TSE:4587
Cash from Operating Activities
¥12.4B
CAGR 3-Years
93%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Takara Bio Inc
TSE:4974
Cash from Operating Activities
¥24.1B
CAGR 3-Years
36%
CAGR 5-Years
26%
CAGR 10-Years
27%
J
Japan Tissue Engineering Co Ltd
TSE:7774
Cash from Operating Activities
-¥138.5m
CAGR 3-Years
16%
CAGR 5-Years
6%
CAGR 10-Years
17%
S
StemRIM Inc
TSE:4599
Cash from Operating Activities
¥1.1B
CAGR 3-Years
25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Oncolys Biopharma Inc's Cash from Operating Activities?
Cash from Operating Activities
-1.3B JPY

Based on the financial report for Dec 31, 2023, Oncolys Biopharma Inc's Cash from Operating Activities amounts to -1.3B JPY.

What is Oncolys Biopharma Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-2%

Over the last year, the Cash from Operating Activities growth was 22%. The average annual Cash from Operating Activities growth rates for Oncolys Biopharma Inc have been 3% over the past three years , -2% over the past five years .